
Global Vaccine Adjuvants Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Vaccine Adjuvants market size was valued at US$ 702 million in 2024 and is forecast to a readjusted size of USD 1234 million by 2031 with a CAGR of 8.5% during review period.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The vaccine adjuvants market is driven by the increasing need for more effective and long-lasting vaccines. Adjuvants are substances added to vaccines to enhance the body’s immune response, making vaccines more effective, especially in cases where the antigen alone may not provide sufficient protection. The growing prevalence of infectious diseases and the rising demand for vaccines to address new and emerging pathogens, such as COVID-19 variants, are fueling the development and adoption of advanced adjuvants. Additionally, ongoing research and development in immunology and biotechnology are leading to the creation of novel adjuvants that improve vaccine efficacy and safety.
One of the main challenges in the vaccine adjuvants market is the complexity and cost associated with developing and producing new adjuvants. The process requires significant investment in research and development, as well as rigorous testing to ensure safety and effectiveness. Additionally, there are regulatory hurdles that must be overcome, as new adjuvants need to meet stringent guidelines before they can be approved for use. Public concerns about vaccine safety and the potential for adverse reactions to adjuvants also pose challenges, as any negative perceptions can impact vaccine acceptance and adoption.
This report is a detailed and comprehensive analysis for global Vaccine Adjuvants market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Vaccine Adjuvants market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Vaccine Adjuvants market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Vaccine Adjuvants market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Vaccine Adjuvants market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vaccine Adjuvants
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vaccine Adjuvants market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, CSL Limited, Croda, SEPPIC, Sanofi, Zhifei Biological, Escon, Huanuotai Biological, Rico Bio, SDA BIO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Vaccine Adjuvants market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Emulsion Adjuvants
Mineral Adjuvants
Others
Market segment by Application
Human Vaccine
Veterinary Vaccine
Major players covered
GSK
CSL Limited
Croda
SEPPIC
Sanofi
Zhifei Biological
Escon
Huanuotai Biological
Rico Bio
SDA BIO
SPI Pharma
Phibro Animal Health
Vertellus
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccine Adjuvants product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vaccine Adjuvants, with price, sales quantity, revenue, and global market share of Vaccine Adjuvants from 2020 to 2025.
Chapter 3, the Vaccine Adjuvants competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine Adjuvants breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Vaccine Adjuvants market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vaccine Adjuvants.
Chapter 14 and 15, to describe Vaccine Adjuvants sales channel, distributors, customers, research findings and conclusion.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The vaccine adjuvants market is driven by the increasing need for more effective and long-lasting vaccines. Adjuvants are substances added to vaccines to enhance the body’s immune response, making vaccines more effective, especially in cases where the antigen alone may not provide sufficient protection. The growing prevalence of infectious diseases and the rising demand for vaccines to address new and emerging pathogens, such as COVID-19 variants, are fueling the development and adoption of advanced adjuvants. Additionally, ongoing research and development in immunology and biotechnology are leading to the creation of novel adjuvants that improve vaccine efficacy and safety.
One of the main challenges in the vaccine adjuvants market is the complexity and cost associated with developing and producing new adjuvants. The process requires significant investment in research and development, as well as rigorous testing to ensure safety and effectiveness. Additionally, there are regulatory hurdles that must be overcome, as new adjuvants need to meet stringent guidelines before they can be approved for use. Public concerns about vaccine safety and the potential for adverse reactions to adjuvants also pose challenges, as any negative perceptions can impact vaccine acceptance and adoption.
This report is a detailed and comprehensive analysis for global Vaccine Adjuvants market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Vaccine Adjuvants market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Vaccine Adjuvants market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Vaccine Adjuvants market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Vaccine Adjuvants market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vaccine Adjuvants
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vaccine Adjuvants market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, CSL Limited, Croda, SEPPIC, Sanofi, Zhifei Biological, Escon, Huanuotai Biological, Rico Bio, SDA BIO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Vaccine Adjuvants market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Emulsion Adjuvants
Mineral Adjuvants
Others
Market segment by Application
Human Vaccine
Veterinary Vaccine
Major players covered
GSK
CSL Limited
Croda
SEPPIC
Sanofi
Zhifei Biological
Escon
Huanuotai Biological
Rico Bio
SDA BIO
SPI Pharma
Phibro Animal Health
Vertellus
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccine Adjuvants product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vaccine Adjuvants, with price, sales quantity, revenue, and global market share of Vaccine Adjuvants from 2020 to 2025.
Chapter 3, the Vaccine Adjuvants competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine Adjuvants breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Vaccine Adjuvants market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vaccine Adjuvants.
Chapter 14 and 15, to describe Vaccine Adjuvants sales channel, distributors, customers, research findings and conclusion.
Table of Contents
108 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Vaccine Adjuvants by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.